In order to further understand the effects of CD44 in ovarian cancer stem cells, an anti-CD44 monoclonal antibody A3D8 was employed to investigate its effects and mechanisms on the proliferation and apoptosis of sphere-forming cells in the human ovarian cancer cell line SKOV-3. This evidence concerns the gene CD44 and ovarian carcinoma.